Login / Signup

Ectopic HCN4 Provides a Target Biomarker for the Genetic Spectrum of mTORopathies.

Matthew ColemanPaulo Pinares-GarciaSarah E StephensonWei Shern LeeDaniz KooshavarCatriona A McleanKatherine B HowellRichard J LeventerChristopher A ReidPaul J Lockhart
Published in: Neurology. Genetics (2024)
HCN4 provides a biomarker for the genetic spectrum of mTORopathies and may present a potential therapeutic target for seizure control in mTOR-related epilepsy.
Keyphrases
  • genome wide
  • cell proliferation
  • risk assessment